Genertec Universal Medical Group Company Limited (2666.HK)

HKD 4.99

(-0.6%)

Market Cap (In HKD)

9.43 Billion

Revenue (In HKD)

13.41 Billion

Net Income (In HKD)

2.11 Billion

Avg. Volume

6.92 Million

Currency
HKD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
3.71-5.87
PE
4.66
EPS
1.07
Beta Value
0.678
ISIN
HK0000255361
CUSIP
Y2774E102
CIK
-
Shares
1891540000.0
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Financial - Credit Services
CEO
Mr. Wang Wenbing
Employee Count
-
Website
https://www.umcare.cn
Ipo Date
2015-07-08
Details
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group segment engages in the provision of medical services; hospital and healthcare management; and import and export trading businesses, as well as trading of medical-related goods. The company is also involved in the provision of medical technology; hospital digitalization, construction, and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.